215 related articles for article (PubMed ID: 27388564)
1. The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model.
Bellamkonda K; Chandrashekar NK; Osman J; Selvanesan BC; Savari S; Sjölander A
BMC Cancer; 2016 Jul; 16():425. PubMed ID: 27388564
[TBL] [Abstract][Full Text] [Related]
2. The impact of inflammatory lipid mediators on colon cancer-initiating cells.
Bellamkonda K; Sime W; Sjölander A
Mol Carcinog; 2015 Nov; 54(11):1315-27. PubMed ID: 25154976
[TBL] [Abstract][Full Text] [Related]
3. M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases.
Vinnakota K; Zhang Y; Selvanesan BC; Topi G; Salim T; Sand-Dejmek J; Jönsson G; Sjölander A
J Cell Physiol; 2017 Dec; 232(12):3468-3480. PubMed ID: 28098359
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3.
Kondeti V; Al-Azzam N; Duah E; Thodeti CK; Boyce JA; Paruchuri S
J Allergy Clin Immunol; 2016 Jan; 137(1):289-298. PubMed ID: 26255103
[TBL] [Abstract][Full Text] [Related]
5. The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.
Osman J; Bellamkonda K; Liu Q; Andersson T; Sjölander A
Anticancer Res; 2019 Apr; 39(4):1719-1728. PubMed ID: 30952711
[TBL] [Abstract][Full Text] [Related]
6. The inflammatory mediator leukotriene D₄ induces subcellular β-catenin translocation and migration of colon cancer cells.
Salim T; Sand-Dejmek J; Sjölander A
Exp Cell Res; 2014 Feb; 321(2):255-66. PubMed ID: 24211746
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene D4-induced adhesion of Caco-2 cells is mediated by prostaglandin E2 and upregulation of alpha2beta1-integrin.
Massoumi R; Nielsen CK; Azemovic D; Sjölander A
Exp Cell Res; 2003 Oct; 289(2):342-51. PubMed ID: 14499635
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications.
O'Connell MR; Sarkar S; Luthra GK; Okugawa Y; Toiyama Y; Gajjar AH; Qiu S; Goel A; Singh P
Sci Rep; 2015 Oct; 5():14983. PubMed ID: 26447334
[TBL] [Abstract][Full Text] [Related]
9. miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1.
Sakaguchi M; Hisamori S; Oshima N; Sato F; Shimono Y; Sakai Y
Mol Cancer Res; 2016 Apr; 14(4):354-62. PubMed ID: 26747706
[TBL] [Abstract][Full Text] [Related]
10. MK2 Regulates Macrophage Chemokine Activity and Recruitment to Promote Colon Tumor Growth.
Phinney BB; Ray AL; Peretti AS; Jerman SJ; Grim C; Pinchuk IV; Beswick EJ
Front Immunol; 2018; 9():1857. PubMed ID: 30298062
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
12. Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.
Chandrakesan P; Yao J; Qu D; May R; Weygant N; Ge Y; Ali N; Sureban SM; Gude M; Vega K; Bannerman-Menson E; Xia L; Bronze M; An G; Houchen CW
Mol Cancer; 2017 Feb; 16(1):30. PubMed ID: 28148261
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
Maccalli C; Parmiani G; Ferrone S
Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848
[TBL] [Abstract][Full Text] [Related]
14. Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer.
Hwang WL; Lan HY; Cheng WC; Huang SC; Yang MH
J Hematol Oncol; 2019 Jan; 12(1):10. PubMed ID: 30683126
[TBL] [Abstract][Full Text] [Related]
15. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
[TBL] [Abstract][Full Text] [Related]
16. Tazarotene-induced gene 1 inhibits prostaglandin E2-stimulated HCT116 colon cancer cell growth.
Tsai FM; Wu CC; Shyu RY; Wang CH; Jiang SY
J Biomed Sci; 2011 Nov; 18(1):88. PubMed ID: 22126303
[TBL] [Abstract][Full Text] [Related]
17. Early growth response gene (EGR)-1 regulates leukotriene D4-induced cytokine transcription in Hodgkin lymphoma cells.
Han H; Xue-Franzén Y; Miao X; Nagy E; Li N; Xu D; Sjöberg J; Björkholm M; Claesson HE
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):122-30. PubMed ID: 26115646
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mucociliary clearance of the eustachian tube by leukotrienes C4 and D4.
Ganbo T; Hisamatsu K; Shimomura S; Nakajima T; Inoue H; Murakami Y
Ann Otol Rhinol Laryngol; 1995 Mar; 104(3):231-6. PubMed ID: 7872607
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo.
Ruan D; So SP
Life Sci; 2014 Oct; 116(1):43-50. PubMed ID: 25139833
[TBL] [Abstract][Full Text] [Related]
20. Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer.
Bellamkonda K; Satapathy SR; Douglas D; Chandrashekar N; Selvanesan BC; Liu M; Savari S; Jonsson G; Sjölander A
Cancer Lett; 2018 Nov; 437():13-24. PubMed ID: 30144515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
